Frontlight ResearchEarly access
CompletedNo phase
Effectiveness and Safety of Embosphere Microspheres for Embolization of the Geniculate Artery for the Treatment of Pain With Known Moderate to Severe Knee Osteoarthritis
Key facts
- Who runs it
- University of Miami
- Where
- Miami, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 9 people enrolled
- Started
- 8 Dec 2022
- Ended
- 2 Jun 2026
- Type of study
- Interventional
- Treatments tested
- Embosphere Microspheres
- Record updated
- 17 July 2026
Who can take part
- Age
- 40 years to 80 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 20 criteriaShow less
Who can take part
- Subject has signed informed consent
- Subject is age 40-80
- Subject is able to have an MRI
- Minimum of prior 12 weeks of failed response to conservative therapy for knee osteoarthritis, which may include one or more of:; Oral or topical NSAIDS, opioid medications, intra-articular injection of glucocorticoids or hyaluronic acid, physical therapy
- Localized tenderness in anterior knee area
- Kellgren-Lawrence grade 1, 2, or 3 as assessed by weight-bearing knee radiographs
- Synovitis present as assessed by WORMS
- VAS >50 mm
- WOMAC score >30
Who cannot take part
- Prior knee arthroplasty
- Local infection of the target knee(s)
- Allergy to iodinated contrast agents that cannot be managed by prophylaxis
- Hypersensitivity to gelatin products
- Any known condition that limits catheter-based intervention or is a contraindication to embolization
- Active malignancy other than non-melanomatous skin cancer
- Any other condition related to the subject's health and wellbeing deemed exclusionary in the opinion of the investigator
- Rheumatoid arthritis
- Kellgren-Lawrence grade >3
- Osteonecrosis evident by MRI
- Subject is pregnant, breastfeeding, or pre-menopausal and intending to become pregnant
Where in United States
- University of MiamiMiami, United States
About the trial
What the trial wants to find out
The purpose of this research study is to evaluate the effectiveness and safety of a permanent embolic (Embosphere Microspheres) for embolization of the geniculate artery for the treatment of moderate to severe knee osteoarthritis.
The group in the trial
- Embosphere Microspheres groupTreatment being tested
Participants in this group who are receiving standard of care (SOC) embolization surgery for the treatment of moderate to severe knee osteoarthritis will receive the Embospheres Microspheres during scheduled SOC surgery.
Treatment: Embosphere Microspheres
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Prospective, Single Arm Investigation to Assess Effectiveness and Safety of Embosphere Microspheres for Embolization of the Geniculate Artery for the Treatment of Pain With Known Moderate to Severe Knee Osteoarthritis
- Record updated
- 17 July 2026